Macular Degeneration

The dry and wet forms differ in the tissue changes that threaten central vision. In dry disease, retinal cell deterioration occurs alongside drusen accumulation. Wet disease is marked by abnormal vessels beneath the retina, with leakage of fluid or blood that disrupts photoreceptors. This distinction matters because disease form influences clinical management and the treatments being investigated.

Drusen accumulation is an important retinal feature of the dry form, but it occurs alongside deterioration of retinal cells. Together, these findings help characterize tissue changes occurring without the abnormal vessel growth described for wet disease. Recognizing this contrast supports clinical assessment and helps separate disease patterns when monitoring macular degeneration over time.

When abnormal blood vessels grow beneath the retina, their leakage of fluid or blood can disturb photoreceptors, the light-sensitive cells needed for retinal signaling. Photoreceptor disruption provides a mechanism linking the vascular abnormality to impaired sharp vision. This relationship also explains why anti-vascular treatments are a major care and research focus for wet disease.

Clinical evaluation combines visual assessment with retinal imaging rather than relying on symptoms alone. Visual assessment examines the functional effect on sight, while imaging helps identify retinal changes and follow progression. Together, these approaches give clinicians information for determining how the condition is changing and for guiding care over time.

Low-vision rehabilitation provides a care pathway for people whose remaining vision no longer supports tasks such as reading, driving, or recognizing faces easily. The source identifies rehabilitation as a management application alongside clinical monitoring and treatment. Its inclusion shows that care addresses daily visual function in addition to retinal findings and disease progression.

Research extends beyond controlling established disease. For wet macular degeneration, anti-vascular treatments address the context of abnormal vessel growth and leakage. Other investigations explore protective and regenerative therapies, reflecting complementary research goals. These directions broaden future care beyond detection and monitoring by seeking approaches that protect retinal cells or address damage associated with the disease.